• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Deals Relating to Cloud Increased Significantly in the Pharmaceutical Industry in H2 2021

Share:

March 28, 2022

In the second half of 2021, the number of deals relating to the cloud increased significantly by 100% from the same period in 2020.

This marks an acceleration in growth from the 72.7% decrease in deals that occurred in H1 2021 relative to the same period a year earlier.

GlobalData’s deals database looks at mergers, acquisitions, venture capital, and private equity investments taking place daily between thousands of companies across the world.

During the second half of 2021, deals relating to the cloud accounted for 0.6% of all deals taking place in the sector. This represents an increase from the figure of 0.1% in the second half of 2020.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

GlobalData’s thematic approach to sector activity seeks to group key company information on investments to see which industries are best placed to deal with any issues they may encounter.

These themes, of which cloud is one, are best thought of as “any issue that keeps a CEO awake at night”, and by tracking them, it becomes possible to ascertain which companies are leading the way on specific issues and which ones have some work to do.

Source: Pharmaceutical-technology

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Roche Delays Spark Buyout Again as U.S. and U.K. Regulators Continue to Review The DealRoche Delays Spark Buyout Again as U.S. and U.K. Regulators Continue to Review The Deal
  • FTC Action on Health Data Sharing Could Put Digital Health ’On Notice’FTC Action on Health Data Sharing Could Put Digital Health ’On Notice’
  • Care.Ai Secures $27M for AI-Powered Smart Patient RoomsCare.Ai Secures $27M for AI-Powered Smart Patient Rooms
  • Heritage Global Patents & Trademarks to Conduct Sealed-Bid Auction of all Remaining Assets of Martin Manufacturing and its innoHeritage Global Patents & Trademarks to Conduct Sealed-Bid Auction of all Remaining Assets of Martin Manufacturing and its inno
  • Liva Healthcare to Partner with German Sick FundsLiva Healthcare to Partner with German Sick Funds
  • FDA Publishes List of Priority Patient Preference Areas for Medical DevicesFDA Publishes List of Priority Patient Preference Areas for Medical Devices
  • BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and CanadaBioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada
  • Opentrons Announces $200 Million Series C Round Led By Softbank Vision Fund 2Opentrons Announces $200 Million Series C Round Led By Softbank Vision Fund 2

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications